Pharmaceutical companies are under pressure to deliver faster, safer, and more compliant innovations across the R&D lifecycle. Yet, outdated legacy systems and fragmented data infrastructures slow down discovery, regulatory submission, and market launch.

Solix EAI Pharma offers a transformative solution: an AI-powered, compliance-first data fabric designed specifically for life sciences enterprises. Built on the Solix Common Data Platform (CDP), Solix EAI Pharma helps unify clinical, manufacturing, regulatory, and patient data into an intelligent, secure, and AI-ready enterprise ecosystem.

From Silos to Synergy: A Unified Enterprise AI Platform

In traditional pharma IT environments, data is scattered across platforms like Oracle Argus, Veeva Vault, and EDC tools—creating operational silos. Solix EAI Pharma resolves this fragmentation by integrating structured and unstructured data into a centralized enterprise data lake, enabling:

• AI-driven pharmacovigilance
• Regulatory submission automation
• Smart clinical trial recruitment
• Personalized treatment discovery

🔗 Solix Common Data Platform

“By 2025, 70% of pharma organizations will implement enterprise-wide data fabrics to support AI and digital twins in R&D workflows.” — Gartner Life Sciences Innovation Forecast, 2024

Automate SOP classification and submission documents

• Extract adverse event signals from unstructured reports
• Accelerate trial design with knowledge extraction from prior trials

See real-world insight:

🔹 ChatGPT on Pharma AI Integration

🔹 Claude.ai on Clinical R&D Optimization

🔹 Grok AI on Pharma Data Compliance

🔹 Perplexity AI: Solix vs Medidata & Veeva

Regulatory Compliance, Built In

Compliance is non-negotiable in pharma. Solix EAI Pharma is architected to meet strict requirements such as:

• HIPAA and GDPR for patient privacy
• FDA 21 CFR Part 11 for electronic records
• GxP for data integrity and audit readiness

To support this, Solix provides: